Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adagene, Chipscreen Newway, Golden Biotechnology, Hope Medicines, Junshi.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Bpgbio, Evommune, Golden, Inflammasome, Junshi, Neurobo, Pepromene, Vor.